Female Med Students Publish Less, Despite Higher Number of Research Experiences
WEDNESDAY, Oct. 26, 2022 (HealthDay News) — Among medical school students, there are...
Read More
Hematology/Oncology
Medically Tailored Meals Could Avert Hospitalizations, Yield Savings
WEDNESDAY, Oct. 26, 2022 (HealthDay News) — For individuals with diet-sensitive conditions,...
Read More
Many Females Receiving HPV Vaccination After Recommended Age
TUESDAY, Oct. 25, 2022 (HealthDay News) — Many females receive human papillomavirus (HPV)...
Read More
USPSTF: Evidence Still Lacking for Routine Skin Cancer Screening
TUESDAY, Oct. 25, 2022 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF)...
Read More
Woman Sues L’Oreal Over Claim Hair Straightener Spurred Uterine Cancer
TUESDAY, Oct. 25, 2022 (HealthDay News) — A Missouri woman has sued L’Oréal and...
Read More
Dove, TRESemmé Dry Shampoos Recalled Due to Possible Carcinogen
TUESDAY, Oct. 25, 2022 (HealthDay News) — Unilever announced Monday that it has recalled...
Read More
Transcriptomic: TC PD-L1 Expression & Nivolumab Monotherapy
The relevance of PD-L1 expression on tumor cells (TC) in clear cell renal cell carcinoma (ccRCC)...
Read More
Nivolumab Promising for Treatment of Advanced Cutaneous SCC
MONDAY, Oct. 24, 2022 (HealthDay News) — For advanced cutaneous squamous cell carcinoma...
Read More
MCL Complications Mostly Due to Underlying Disease, Not Treatment
“New treatments for mantle cell lymphoma (MCL) have improved survival and increased the life...
Read More
NUDT15 Expression Levels: Biallelic NUDT15 Variants & 6-MP Intolerance
Pediatric lymphoma and leukemia are commonly treated with 6-Mercaptopurine (6-MP). Germline...
Read More
Clinicopathological Characteristics & Plasmablastic Lymphoma
There was no standard of treatment for the aggressive and uncommon subtype of non-Hodgkin lymphoma...
Read More
Nivolumab Plus Ipilimumab Vs. Chemotherapy: Survival Outcome
For a study, researchers sought to provide 5-year findings from CheckMate 227 Part 1 in which...
Read More
DNA Replication Regulator ORCs in Lung Adenocarcinomas
Patients with lung adenocarcinoma (LUAD) is characterized by DNA replication alteration, which is...
Read More
New Platform Matches Patients to Precision Oncology Trials
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — A new open-source platform speeds matching of...
Read More
Physicians With Disabilities Experience More Mistreatment
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — Physicians with disabilities had a significantly...
Read More
Exercise Intervention During Chemotherapy Beneficial
THURSDAY, Oct. 20, 2022 (HealthDay News) — An exercise intervention performed during...
Read More
Hair Straightening Product Use Linked to Uterine Cancer
THURSDAY, Oct. 20, 2022 (HealthDay News) — Use of hair straightening products appears to be...
Read More
Eltrombopag & Azacitidine in High-risk Myelodysplastic Syndromes Patients
Thrombocytopenia is made worse when myelodysplastic syndromes with high risk are treated with...
Read More
Palladin Promotes CSCs-like Properties in Lung Cancer
Drug resistance, cancer recurrence, and metastasis are all caused by cancer stem cells (CSCs). For...
Read More
Thrombotic Risk Factors in 1381 ET Patients: Validation
Patients with essential thrombocythaemia (ET) frequently have thrombosis and hemorrhage. Patients...
Read More